Name:
Osteobac – Radiofarma®

Active Principle:
Methylenephosphonic Acid

Therapeutic Action:
It is indicated for performing bone scintigraphy which allows evaluating areas with altered osteogenesis associated with:

1.- Neoplasia:

•  Osteosarcoma staging
•  Detection and monitoring of bone metastases

2.- Non-neoplastic lesions, as an aid in the evaluation of :

•  Osteomyelitis
•  Avascular necrosis
•  Paget’s disease
• Stress fractures
•  Tibial periostitis
•  Detection of loose or infected prostheses when conventional radiography has already been performed and is inconclusive
•  Reflex sympathetic syndrome
•  Bone graft viability